We are live on ! Find out more
LFM

Lumina Fund Management Portfolio holdings

AUM $164M
1-Year Est. Return 27.72%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+27.72%
3 Year Est. Return
+28.12%
5 Year Est. Return
+101.22%
10 Year Est. Return
+153.06%
AUM
$2.11B
AUM Growth
+$1.25B
Cap. Flow
+$1.22B
Cap. Flow %
58.03%
Top 10 Hldgs %
95.29%
Holding
63
New
15
Increased
5
Reduced
10
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 1.25%
2 Healthcare 0.4%
3 Energy 0.38%
4 Consumer Discretionary 0.32%
5 Communication Services 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
51
CALL
Mastercard
MA
$506B
-90,000
Closed -$6.97M
PRU icon
52
CALL
Prudential Financial
PRU
$42.4B
-75,000
Closed -$6M
RL icon
53
CALL
Ralph Lauren
RL
$22.6B
-38,500
Closed -$6.16M
RMD icon
54
CALL
ResMed
RMD
$30.6B
-100,000
Closed -$4.5M
STT icon
55
CALL
State Street
STT
$50.6B
-96,000
Closed -$6.48M
VFC icon
56
CALL
VF Corp
VFC
$5.63B
-9,558
Closed -$518K
VOD icon
57
CALL
Vodafone
VOD
$36.3B
-115,000
Closed -$4.25M
WBD icon
58
CALL
Warner Bros
WBD
$65.9B
-52,839
Closed -$2.16M
SLCA
59
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-94,100
Closed -$3.59M
ESRX
60
CALL
DELISTED
Express Scripts Holding Company
ESRX
-6,500
Closed -$488K
CTRX
61
CALL
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
-50,000
Closed -$2.38M
CELG
62
DELISTED
Celgene Corp
CELG
-82,000
Closed -$5.72M
TWC
63
CALL
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-4,000
Closed -$560K

Similar funds

Lumina Fund Management's Q2 2014 Portfolio in Review

As of Q2 2014, Lumina Fund Management held 63 positions worth $2.11B, up 146% from $857M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Lumina Fund Management deployed $1.22B of net new capital in Q2 2014, opening 15 new positions and adding to 5 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 24,700 shares worth $6.98M.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 3.3% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Teradata, an estimated $6.3M trimmed.

  • Lumina Fund Management's largest Q2 2014 buy was Regeneron Pharmaceuticals: 24,700 shares worth $6.98M.
  • Lumina Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $20.3M increase.
  • Lumina Fund Management's biggest Q2 2014 reduction was Teradata, cutting an estimated $6.3M.
  • Lumina Fund Management fully exited Celgene Corp in Q2 2014, selling an estimated $5.72M.
  • Lumina Fund Management's ten largest holdings make up 95% of its $2.11B portfolio in Q2 2014.
  • Lumina Fund Management opened 15 new positions and closed 22 in Q2 2014.
  • Lumina Fund Management's portfolio value rose 146% quarter-over-quarter to $2.11B.

Based on Lumina Fund Management's 13F filing for Q2 2014, filed 14 Aug 2014.